NLS Pharmaceutics Ltd (NLSP)
3.60
-0.03
(-0.83%)
USD |
NASDAQ |
Nov 01, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Price: 3.60 for Nov. 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 01, 2024 | 3.81 | 3.81 | 3.56 | 3.60 | 8543.00 |
Oct 31, 2024 | 3.65 | 3.90 | 3.63 | 3.63 | 7564.00 |
Oct 30, 2024 | 4.20 | 4.385 | 3.510 | 3.86 | 28965.00 |
Oct 29, 2024 | 4.09 | 4.23 | 3.90 | 4.13 | 19216.00 |
Oct 28, 2024 | 4.18 | 4.200 | 3.80 | 4.11 | 60691.00 |
Oct 25, 2024 | 4.30 | 4.46 | 4.18 | 4.18 | 8934.00 |
Oct 24, 2024 | 4.497 | 4.65 | 4.22 | 4.26 | 14069.00 |
Oct 23, 2024 | 4.70 | 4.95 | 4.30 | 4.605 | 27232.00 |
Oct 22, 2024 | 5.00 | 5.177 | 4.75 | 4.84 | 10678.00 |
Oct 21, 2024 | 5.20 | 5.40 | 4.52 | 4.760 | 51663.00 |
Oct 18, 2024 | 5.00 | 5.643 | 4.85 | 5.30 | 28294.00 |
Oct 17, 2024 | 5.00 | 5.25 | 4.889 | 5.18 | 17982.00 |
Oct 16, 2024 | 4.94 | 5.24 | 4.66 | 5.08 | 44153.00 |
Oct 15, 2024 | 4.52 | 4.78 | 4.379 | 4.77 | 23914.00 |
Oct 14, 2024 | 4.60 | 4.60 | 4.46 | 4.59 | 14909.00 |
Oct 11, 2024 | 4.55 | 4.55 | 4.100 | 4.45 | 35967.00 |
Oct 10, 2024 | 5.01 | 5.01 | 4.14 | 4.25 | 67126.00 |
Oct 09, 2024 | 5.22 | 5.295 | 5.04 | 5.096 | 8078.00 |
Oct 08, 2024 | 5.08 | 5.355 | 4.99 | 5.28 | 24814.00 |
Oct 07, 2024 | 5.10 | 5.20 | 4.888 | 5.064 | 19684.00 |
Oct 04, 2024 | 4.955 | 5.19 | 4.724 | 4.90 | 20170.00 |
Oct 03, 2024 | 4.98 | 5.19 | 4.72 | 4.875 | 13154.00 |
Oct 02, 2024 | 5.20 | 5.20 | 4.898 | 4.98 | 6656.00 |
Oct 01, 2024 | 4.89 | 5.50 | 4.72 | 5.20 | 31400.00 |
Sep 30, 2024 | 5.15 | 5.20 | 4.742 | 5.07 | 64509.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.60
Minimum
Nov 01 2024
234.00
Maximum
Mar 12 2021
49.24
Average
36.34
Median
Feb 04 2022
Price Benchmarks
AC Immune SA | 3.00 |
CRISPR Therapeutics AG | 50.76 |
Addex Therapeutics Ltd | 10.70 |
Molecular Partners AG | 6.12 |
MoonLake Immunotherapeutics | 46.76 |
Price Related Metrics
Earnings Yield | -187.2% |
Market Cap | 13.73M |